Aveo Pharmaceuticals, a biotechnology company, has initiated a Phase Ib/IIa clinical trial of AV-951 as monotherapy for the treatment of advanced non-small cell lung cancer. This new trial
US-based Celator Pharmaceuticals has treated the first patient in its Phase II multicenter, randomized, open-label clinical trial of CPX-351 liposome injection versus intensive salvage therapy in adult patients,
According to Bellus Health, the current programs related to the company’s existing product and product candidates will not be affected by the cuts, which are being made primarily
The increase in net loss for the fourth quarter of 2008, as compared to the fourth quarter of 2007, was primarily due to a decrease in interest income
Revenues for the fourth quarter ended December 31, 2008 were $2.9 million, up from $2.1 million for the corresponding period in 2007. Revenues for the full-year 2008 totaled
Drugstore chain Duane Reade Holdings has reported total net sales of $464.5m in the fourth quarter of 2008, an increase of 7.6%, compared to $431.6m in the fourth
Total revenues for the three months ended December 31, 2008 were $6.2 million, compared to $2.2 million for the fourth quarter of 2007. Net income for the year
The company reported total revenues of $176,885 for the fourth quarter of 2008, compared to $222,334 for the same quarter of 2007. Total revenues for the year ended
Prasco, as GlaxoSmithKline’s (GSK’s) agent and on GSK’s behalf, will solicit orders for, and distribute fluticasone propionate nasal spray to all trade classes in the US under a
Utilizing its flagship product, Ensemble for Life Science, ArtusLabs said that it created a system that combines access of structured, database-driven data with unstructured data in the same
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.